Page last updated: 2024-09-05

n(4)-hydroxycytidine and leflunomide

n(4)-hydroxycytidine has been researched along with leflunomide in 1 studies

Compound Research Comparison

Studies
(n(4)-hydroxycytidine)
Trials
(n(4)-hydroxycytidine)
Recent Studies (post-2010)
(n(4)-hydroxycytidine)
Studies
(leflunomide)
Trials
(leflunomide)
Recent Studies (post-2010) (leflunomide)
421321,725173659

Protein Interaction Comparison

ProteinTaxonomyn(4)-hydroxycytidine (IC50)leflunomide (IC50)
Dihydroorotate dehydrogenase (quinone), mitochondrialMus musculus (house mouse)0.03
Cytochrome P450 1A2Homo sapiens (human)0.5
Aldo-keto reductase family 1 member B1Rattus norvegicus (Norway rat)4.63
Sodium-dependent noradrenaline transporter Homo sapiens (human)4.63
Sodium-dependent dopamine transporter Homo sapiens (human)2.884
Dihydroorotate dehydrogenase (quinone), mitochondrialHomo sapiens (human)5.4
Dihydroorotate dehydrogenase (quinone), mitochondrialRattus norvegicus (Norway rat)0.009

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Clement, B; Indorf, P; Kubitza, C; Kunze, T; Scheidig, AJ1

Other Studies

1 other study(ies) available for n(4)-hydroxycytidine and leflunomide

ArticleYear
Drug Metabolism by the Mitochondrial Amidoxime Reducing Component (mARC): Rapid Assay and Identification of New Substrates.
    Journal of medicinal chemistry, 2020, 06-25, Volume: 63, Issue:12

    Topics: Biological Assay; Humans; Inactivation, Metabolic; Metabolic Clearance Rate; Mitochondria; Mitochondrial Proteins; Oxidation-Reduction; Oxidoreductases; Oximes; Substrate Specificity

2020